TRLVTrulieve Cannabis Corp. Subordinate Voting Shares
+4.0% today · +65.3% over a year
3/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 37% of the instruments we score
Stability: among the weakest. No dividend.
Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV) belongs to the Health care sector and is listed on NYSE; country: United States. Its market value is about €2B. Over the past 12 months the price changed by +65.3%, with an annualised volatility of 101% and a largest fall of 54%.
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in USA (n = 337)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Volatility (1 y)weighs on the score · better than 6% of peers
- Accrualssupports the score · better than 95% of peers
- Free cash flow / EVsupports the score · better than 95% of peers
Red flags and notes
- Caution. Net debt above 4× EBITDA or interest cover below 2×. More in the glossary → Net debt above 4× EBITDA or interest cover below 2×.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 2.9
- P/S
- 1.9
- Free-cash-flow yield
- 9.1%
- Market cap (EUR)
- €2B
Profitability and debt
- Return on equity
- −47.9%
- Return on invested capital
- −30.5%
- Gross margin
- 59.5%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +4.0%
- 1 month
- +7.6%
- 1 year
- +65.3%
- Volatility, 1 yr
- 101.5%
- Max drawdown, 1 yr
- −54.4%
- Beta
- 1.12
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| VERAVera Therapeutics Inc. | 1/10 | 0.0% | 18.4% |
|---|---|---|---|
| PGNYProgyny Inc | 10/10 | 0.0% | 57.7% |
| PVLAPalvella Therapeutics Inc. | —/10 | 0.0% | 99.0% |
| BCRXBioCryst Pharmaceuticals | 3/10 | 0.0% | 24.9% |
| PRGOPerrigo Company plc | 1/10 | 5.5% | −18.1% |
| NEONeoGenomics Inc | 3/10 | 0.0% | 72.1% |
| UFPTUFP Technologies Inc. | 9/10 | 0.0% | 40.8% |
| XNCRXencor Inc | 1/10 | 0.0% | 119.8% |
News and filings
- Trulieve Cannabis Corp.: 8-K — Material agreement; unregistered sale of equity; change to security holders' rights; charter or bylaw amendment
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 11 Aug 2026
- Trulieve Cannabis Corp.: 10-Q — Quarterly report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 7 Aug 2026
- Trulieve Cannabis Corp.: 8-K — Acquisition or disposition completed; Regulation FD disclosure
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 7 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 2 entries
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | 4 → 3/10 | 4 · — | — | Available with Invest Pro | |
| First rating | 4/10 | 4 · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.